NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28/04/2026
Voltar para busca
Dado oficial do USPTO
BIOMATRIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
18
Atualização mais recente
29/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 44
Data de depósito
16/06/2020
Data de registro
12/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2026
Última transação
29/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
17/07/2015
Primeiro uso no comércio
17/07/2015
Código do desenho
3
Tipo de titular
16
Localização do titular
Plantation, FL, US
Examinador
GOLD, BARBARA
Localização atual
Historical data usage
Descrição da marca
The mark consists of the stylized wording "BIOMATRIX" surrounded by square brackets with the left bracket forming the vertical left side of the letter "B" and the right bracket placed to the right and next to the letter "X".
Titulares e representantes
Titulares
BioMatrix Specialty Pharmacy, LLC
Representantes
Gina L. Durham, Esq. DLA PIPER LLP (US)
Classificação técnica
Classes Nice
Classe 35Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Retail pharmacy services; specialty retail pharmacy services; Health care utilization and review services as they relate to prescription drugspharmaceutical cost management and drug review utilization servicesverification of benefitsprior authorization and review services and coordination of delivery and access to prescription drugs; Specialty pharmacy servicesretail pharmaceutical distributorship services in the field of special purpose infusion-basedinjectable and oral pharmaceuticals; Business administration of pharmacy reimbursement programs and services in the field of specialty pharmaceuticals for health benefit plan subscribers; Pharmaceutical cost management services and drug utilization review services for patients with complex or chronic medical conditionsall of the foregoing not including dietary supplements or nutraceuticals
Classe 44
Medical servicesproviding home infusion servicesspecialty infusion servicesambulatory infusion servicesspecialty pharmacy services in the nature of pharmaceutical advice and dispensing of pharmaceuticals; providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals and nutritional therapy services; providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; Skilled nursing services in the nature of medication assistance and infusion services; home-visit nursing care; Providing medical information regarding prescription drugs and drug therapy; providing medical information regarding patients' prescription drugs and drug therapy; developing and managing comprehensive programs comprising medical drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; healthcare services in the nature of providing and administering infusion biologics therapies for transplantimmunologyneurology and hematology; healthcare services in the nature of immunization services; medical evaluation servicesdisease management programs; healthcare assessment services in the field of patient treatment protocols and patient outcomesall of the foregoing not including dietary supplements or nutraceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
18 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/04/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/02/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/01/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
12/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/10/2020
PUBO
PUBLISHED FOR OPPOSITION
27/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
18/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
18/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/09/2020
DOCK
ASSIGNED TO EXAMINER
18/09/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
15/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/07/2020
NWAP
NEW APPLICATION ENTERED
19/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOMATRIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.